DK720488A - Immunokompromitterede kimaerepattedyr og anvendelse heraf til fremstilling af celler og stoffer - Google Patents

Immunokompromitterede kimaerepattedyr og anvendelse heraf til fremstilling af celler og stoffer

Info

Publication number
DK720488A
DK720488A DK720488A DK720488A DK720488A DK 720488 A DK720488 A DK 720488A DK 720488 A DK720488 A DK 720488A DK 720488 A DK720488 A DK 720488A DK 720488 A DK720488 A DK 720488A
Authority
DK
Denmark
Prior art keywords
tissue
xenogeneic
thymus
lymph node
cells
Prior art date
Application number
DK720488A
Other languages
Danish (da)
English (en)
Other versions
DK720488D0 (da
Inventor
Joseph Mccrary Mccune
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22476130&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK720488(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of DK720488D0 publication Critical patent/DK720488D0/da
Publication of DK720488A publication Critical patent/DK720488A/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0271—Chimeric animals, e.g. comprising exogenous cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Environmental Sciences (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • AIDS & HIV (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK720488A 1987-12-23 1988-12-23 Immunokompromitterede kimaerepattedyr og anvendelse heraf til fremstilling af celler og stoffer DK720488A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13717387A 1987-12-23 1987-12-23

Publications (2)

Publication Number Publication Date
DK720488D0 DK720488D0 (da) 1988-12-23
DK720488A true DK720488A (da) 1989-06-24

Family

ID=22476130

Family Applications (1)

Application Number Title Priority Date Filing Date
DK720488A DK720488A (da) 1987-12-23 1988-12-23 Immunokompromitterede kimaerepattedyr og anvendelse heraf til fremstilling af celler og stoffer

Country Status (8)

Country Link
EP (1) EP0322240B1 (fr)
JP (1) JP2801228B2 (fr)
AT (1) ATE119197T1 (fr)
AU (1) AU2754888A (fr)
DE (1) DE3853201T2 (fr)
DK (1) DK720488A (fr)
ES (1) ES2071620T3 (fr)
IL (1) IL88779A (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2981486B2 (ja) * 1988-06-14 1999-11-22 メディカル・バイオロジー・インスティチュート 哺乳動物の免疫系研究方法
US6713610B1 (en) 1990-01-12 2004-03-30 Raju Kucherlapati Human antibodies derived from immunized xenomice
US6150584A (en) * 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6657103B1 (en) 1990-01-12 2003-12-02 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6673986B1 (en) * 1990-01-12 2004-01-06 Abgenix, Inc. Generation of xenogeneic antibodies
US6075181A (en) * 1990-01-12 2000-06-13 Abgenix, Inc. Human antibodies derived from immunized xenomice
WO1991010741A1 (fr) * 1990-01-12 1991-07-25 Cell Genesys, Inc. Generation d'anticorps xenogeniques
EP0438053B1 (fr) * 1990-01-15 1999-06-16 Yeda Research And Development Company Limited Implantation durable et développement d'une lignée hématopoiétique humaine chez des mammifères normaux
US5849288A (en) * 1990-01-15 1998-12-15 Yeda Research And Development Co. Ltd. Method for production of monoclonal antibodies in chimeric mice or rats having xenogeneic antibody-producing cells
US5652373A (en) * 1990-01-15 1997-07-29 Yeda Research And Development Co. Ltd. Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems
US5061620A (en) * 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5147784A (en) * 1990-04-12 1992-09-15 Systemix, Inc. T-lymphocyte progenitor cell assay
CA2063408A1 (fr) * 1990-05-03 1991-11-04 Susan Mayo Tissu lymphoide humain d'un hote immunodeprime
WO1991018615A1 (fr) * 1990-05-25 1991-12-12 Systemix, Inc. Globules de sang peripherique humain chez un hote presentant un deficit immunitaire
DK9091D0 (da) * 1991-01-18 1991-01-18 Novo Nordisk As Fremgangsmaade til fremstilling af antistoffer
US5858328A (en) * 1991-06-04 1999-01-12 Yeda Research And Development Co. Ltd. Animal model for hepatitis virus infection
US5849987A (en) * 1992-06-02 1998-12-15 Yeda Research And Development Co. Ltd. Animal model for hepatitis virus infection
US5804160A (en) * 1991-06-04 1998-09-08 Yeda Research And Development Co. Ltd Animal model for hepatitis virus infection
EP0539970B1 (fr) * 1991-10-30 1999-05-26 Idemitsu Kosan Company Limited Procédés de production des lymphocytes humains et des anticorps humains, et anticorps humains ainsi produits
US6353150B1 (en) * 1991-11-22 2002-03-05 Hsc Research And Development Limited Partnership Chimeric mammals with human hematopoietic cells
NL9102122A (nl) * 1991-12-18 1993-07-16 Tno Werkwijze voor het testen van antivirale middelen; daarvoor bruikbare proefdieren.
US5866757A (en) * 1992-06-02 1999-02-02 Yeda Research And Development Co. Ltd. Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems
WO1994016080A1 (fr) * 1993-01-08 1994-07-21 Exemplar Corporation Procede in vitro/in vivo d'identification de medicaments anti-neoplasiques
GB9317766D0 (en) * 1993-08-26 1993-10-13 Agricultural & Food Res Animal models
US5972627A (en) * 1994-06-15 1999-10-26 Systemix, Inc. Method of purifying a population of cells enriched for dendritic and/or lymphoid progenitors and populations of cells obtained thereby
US5985660A (en) * 1994-06-15 1999-11-16 Systemix, Inc. Method of identifying biological response modifiers involved in dendritic and/or lymphoid progenitor cell proliferation and/or differentiation
WO1996001120A1 (fr) * 1994-07-03 1996-01-18 P.N. Gerolymatos S.A. Produits thymiques et applications
US6455756B1 (en) * 1994-08-12 2002-09-24 Novartis Ag Long term xenogeneic myeloid and lymphoid cell production in chimeric immunocompromised mice
WO1996039811A1 (fr) * 1995-06-07 1996-12-19 Novartis Ag Animaux immunodeprimes a tissu synovial humain
US6015554A (en) * 1995-06-07 2000-01-18 Systemix, Inc. Method of reconstituting human lymphoid and dendritic cells
US5986170A (en) 1995-11-13 1999-11-16 Corixa Corporation Murine model for human carcinoma
EP1500329B1 (fr) 1996-12-03 2012-03-21 Amgen Fremont Inc. Les anticorps humains qui lient en particulier l'alpha de TNF humain
JP2002503091A (ja) 1997-03-26 2002-01-29 リプロジェン，インコーポレイテッド 子宮内膜症マウスモデル
EP0973381B1 (fr) * 1997-04-09 2010-03-03 AMDL, Inc. Model animal aux fins d'une appréciation de vaccins
EP1079688A1 (fr) * 1998-05-26 2001-03-07 Innogenetics N.V. Procede permettant d'augmenter des lymphocytes b de primates chez la souris immunodeprimee, et de produire de grands nombres de lymphocytes b specifiques de l'antigene pour la production d'anticorps monoclonaux de primates
TW200813086A (en) 2006-05-11 2008-03-16 Hoffmann La Roche Immunereconstituted mouse
SG10201403703XA (en) * 2009-06-29 2014-10-30 Qingfeng Chen Methods of producing humanized non-human mammals
US8541646B2 (en) 2009-10-06 2013-09-24 Regeneron Pharmaceuticals, Inc. Genetically modified mice and engraftment
KR102109172B1 (ko) 2011-02-15 2020-05-12 리제너론 파마슈티칼스 인코포레이티드 인간화된 ｍ－ｃｓｆ 마우스
IL282472B2 (en) 2012-09-07 2024-04-01 Regeneron Pharma Genetically modified non-human animals and methods of their use
SG10201707449TA (en) 2012-11-05 2017-10-30 Regeneron Pharma Genetically modified non-human animals and methods of use thereof
ES2854276T3 (es) 2014-05-19 2021-09-21 Regeneron Pharma Animales no humanos modificados genéticamente que expresan EPO humana
WO2016168212A1 (fr) 2015-04-13 2016-10-20 Regeneron Pharmaceuticals, Inc. Souris "knockin" sirpa-il15 humanisées et leurs procédés d'utilisation

Also Published As

Publication number Publication date
DK720488D0 (da) 1988-12-23
DE3853201T2 (de) 1995-09-14
IL88779A (en) 1995-07-31
ES2071620T3 (es) 1995-07-01
JPH0231632A (ja) 1990-02-01
AU2754888A (en) 1989-06-29
EP0322240A2 (fr) 1989-06-28
ATE119197T1 (de) 1995-03-15
EP0322240B1 (fr) 1995-03-01
IL88779A0 (en) 1989-07-31
EP0322240A3 (en) 1990-04-18
DE3853201D1 (de) 1995-04-06
JP2801228B2 (ja) 1998-09-21

Similar Documents

Publication Publication Date Title
DK720488A (da) Immunokompromitterede kimaerepattedyr og anvendelse heraf til fremstilling af celler og stoffer
Jensen et al. A simple organ culture method which allows simultaneous isolation of specific types of cells
Goldenberg et al. Malignant potential of murine stromal cells after transplantation of human tumors into nude mice
DE3262697D1 (en) Method for producing self-reproducing mammalian pancreatic islet-like structures
FI820075L (fi) Rekombination-dna-medel och foerfarande
FI92258B (fi) Onkostatiini-A:n käyttö diagnostisessa menetelmässä
DE69534227D1 (de) Stoffe und verfahren zur beherrschung der hyperakuten abstossung von menschlichen transplantaten
DK639689D0 (da) Indfoering af dna i celler
DE3874019T2 (de) Verfahren zur konservierung von transplantierbaren, in vitro kultivierten epithelgeweben.
Vallee et al. Purification of microtubules and microtubule-associated proteins from sea urchin eggs and cultured mammalian cells using taxol, and use of exogenous taxol-stabilized brain microtubules for purifying microtubule-associated proteins
CA2213322A1 (fr) Thiols utilises pour favoriser la croissance de cellules hematopoietiques parentes
PT941329E (pt) Metodo para prevenir a rejeicao de enxertos em transplantacao e para produzir uma celula-hospedeiro para terapia genetica universal utilizando activacao de linfocitos (lag-3)
ATE361975T1 (de) Tiermodell für hepatitis-virus infektion
ATE15693T1 (de) Zellkultur-verfahren.
FI913266A0 (fi) Foerfarande foer infoerande av exogen dna i djurets somatiska och groddceller.
KITAMURA THE IN VITRO CULTIVATION OF TISSUES FROM THE MOSQUITOES: III. Further studies on the cultivation of ovarian tissues of three mosquito species and the examination of the origin of cells grown in vitro
IL60419A (en) Surface culture of eukariotic cells and production of physiologically active substances from the cells thus obtained
DE3785109D1 (de) Immortalisierung durch dns-uebertragung.
Weterings et al. Serially cultured keratinocytes from human scalp hair follicles: a tool for cytogenetic studies
DE60025036D1 (de) Verfahren zur züchtung von haftenden tierischen zellen
DE69920216D1 (de) Biologisches material zur herstellung pharmazeutischer zusammensetzungen zur behandlung von säugetieren
Prachar et al. Retrovirus like particles produced by human embryonal cells and cell lines derived from human malignancies. II. Protein structure
NZ195671A (en) Preserving monolayers of tissue culture cells by coating with wax
Dombrowski et al. Phosphorylation of biologically active analogs of riboflavin
CU21089A (es) Procedimiento para el cultivo de microalgas en agua residuales de la levaura forrajera

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment